-
-
-
-
-
-
-
Oncternal Therapeutics Announces Closing of $86.2 Million Bought Deal and Full Exercise of Option to Purchase Additional Shares
-
-
-
-
-
-
-
Oncternal Therapeutics to Participate in September Investor Conferences
-
-
-
-
-
-
-
Oncternal Therapeutics Announces $5.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
21,311 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

